Literature DB >> 322206

Hyperthermic effects on animal tissues.

H D Suit.   

Abstract

TCD50 values for thermally resistant tumors have been significantly reduced. The therapeutic ratio has been improved for some tumor-normal tissue situations and treatment protocols, but not for others. The oxygen enhancement ratio (OER) for hyperthermic damage may be congruent to 1; if this is true for tumor cells in vivo, the combination of hyperthermia and radiation should improve the therapeutic ratio to the extent that hypoxic cells are critical. There does not appear to be a differential response to hyperthermia by the normal foot or tumor growing in the foot pad for the following two parameters: (a) relationship between heating time to produce the specified response and the level of heating, and (b) effect of fractionation of hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322206     DOI: 10.1148/123.2.483

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  THERMAL DOSE REQUIREMENT FOR TISSUE EFFECT: EXPERIMENTAL AND CLINICAL FINDINGS.

Authors:  Mark W Dewhirst; Benjamin L Viglianti; Michael Lora-Michiels; P Jack Hoopes; Margaret Hanson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2003-06-02

Review 2.  Hyperthermia in cancer therapy.

Authors:  J Otte
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

3.  Circulatory and metabolic responses of malignant tumors during localized hyperthermia.

Authors:  P Vaupel; K Ostheimer; W Müller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  Hyperthermia in cancer therapy.

Authors:  K H Luk; R M Hulse; T L Phillips
Journal:  West J Med       Date:  1980-03

5.  Oxygenation of malignant tumors after localized microwave hyperthermia.

Authors:  P W Vaupel; J Otte; R Manz
Journal:  Radiat Environ Biophys       Date:  1982       Impact factor: 1.925

6.  Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.

Authors:  H Gerad; M J Egorin; M Whitacre; D A Van Echo; J Aisner
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Influence of hyperthermia on the oxygen enhancement ratio for x-rays, measured in vivo.

Authors:  C C Morris; S B Field
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

8.  Hyperthermia and the heat-shock proteins of HeLa cells.

Authors:  R H Burdon; A Slater; M McMahon; A C Cato
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.